Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Standalone and consolidated results for quarter and half year ended 30.09.2025
Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Quarter And Half Year Ended 30.09.2025
Filed with BSE · · 1 page · English
Release
Earlier from Supha Pharmachem
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Supha Pharmachem Ltd Press Release Nov 04 2025
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Supha Pharmachem Ltd Press Release Oct 31 2025
- Appointment Of Mr. Rambhajan Vishwakarma And Mr. Vignesh Laxman Gawde
Later from Supha Pharmachem
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Supha Pharmachem Ltd Press Release Nov 10 2025
- Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2025
- Results - Financial Results For Quarter And Half Year Ended September 30, 2025
- Supha Pharmachem Ltd Press Release Nov 14 2025
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem